How Ozempic Is Changing Diabetes Treatmentnews2024-05-13T15:00:06+00:00May 13th, 2024|The New York Times|
Insulin Cost Is a Key Campaign Issue for Bidennews2024-05-04T09:02:14+00:00May 4th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Your Inhalers and EpiPens Aren’t Very Healthy for the Environmentnews2024-02-26T17:10:53+00:00February 26th, 2024|The New York Times|
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cutsnews2023-03-24T15:25:37+00:00March 24th, 2023|The New York Times|
Sanofi Plans to Cut the Price of Insulinnews2023-03-16T22:26:17+00:00March 16th, 2023|The New York Times|
Novo Nordisk Says It Will Slash the Price of Insulinnews2023-03-14T18:25:13+00:00March 14th, 2023|The New York Times|
Eli Lilly to Cut Insulin Price and Cap Monthly Out of Pocket Costs at $35news2023-03-02T03:22:18+00:00March 2nd, 2023|The New York Times|
California Sues Companies Over Insulin Prices, Joining Other Statesnews2023-01-18T17:16:35+00:00January 18th, 2023|The New York Times|
Medicare Begins to Rein In Drug Costs for Older Americansnews2023-01-14T16:52:43+00:00January 14th, 2023|The New York Times|
